Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non-small Cell Lung Cancer
- Publisher
- CLINICAL CANCER RESEARCH
- Language
- 영어
- ISSN
- 1078-0432
- Citation Volume
- 27
- Citation Number
- 4
- Citation Start Page
- 992
- Citation End Page
- 1002
- 파일 목록
-
-
관련 파일이 존재하지 않습니다.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.